Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics Third Quarter 2024 Results Conference Call.
Plus Therapeutics Inc. (PSTV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.50 | 4,000 | 15,188 | 2024-09-13 | Filing | ||
| $1.35 | 6,285 | 11,188 | 2024-09-12 | Filing | ||
| $1.35 | 12,500 | 48,921 | 2024-09-11 | Filing | ||
| $1.34 | 5,000 | 26,497 | 2024-09-11 | Filing | ||
| $1.23 | 8,000 | 20,425 | 2024-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.96 | 2,068 | Officer, Director | 170 | 2023-11-20 | Filing | |
| $0.31 | 1,500 | Director | 8,500 | 2022-12-30 | Filing | |
| $0.34 | 473,831 | Large Shareholder | 4,543,086 | 2018-02-14 | Filing | |
| $0.31 | 101,710 | Large Shareholder | 5,016,917 | 2018-02-13 | Filing | |
| $0.31 | 185,272 | Large Shareholder | 5,118,627 | 2018-02-12 | Filing |
Institutional Investors' Holdings
News See All
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to Plus’ Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics' First Quarter 2024 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript
Plus Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.7, expectations were $-0.78.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Third Quarter 2023 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Second Quarter 2023 Results Conference Call.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Fourth Quarter and Full Year 2022 Results Conference Call.